Independent Director · Summit Therapeutics Inc. (SMMT)

Alessandra Cesano director compensation at Summit Therapeutics: $640K

Fiscal year 2025 director compensation for Alessandra Cesano at Summit Therapeutics Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 17, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Alessandra Cesano’s full pay file as a PDF — free

More than this page: up to 10 years of Alessandra’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Alessandra Cesano and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Summit Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Summit Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$28,200$0$611,981$0$640,181
FY2023$27,250—$199,744—$226,994
FY2022$6,181—$159,183—$165,364

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Summit Therapeutics Inc. DEF 14A filed April 17, 2026, accession 0001599298-26-000029, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Summit Therapeutics Inc. filed document, accession 0001599298-26-000029. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Get the Summit Therapeutics Board Governance Report

$640,181 Alessandra Cesano, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 17, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Summit Therapeutics pays directors a $49,900 cash retainer and $35,000 in Options.

Committees

FY2025 · as the proxy prints them

Nominating/Governance

The rest of the Summit Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Jeff HuberIndependent Director$649,186
Kenneth A. ClarkLead Independent Director$835,697
Mahkam ZanganehDirector—
Manmeet SoniDirector—
Mostafa RonaghiIndependent Director$625,486
Robert BoothIndependent Director$672,773
Robert W. DugganChair of the Board—
Yu (Michelle) XiaDirector$649,996

The full Summit Therapeutics compensation record

free company brief

This page is one director within Summit Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order SMMT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report